CO [China Cord Blood] 6-K: (Original Filing)

[China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2012 4Q12 New Subscribers reached 14,336 4Q12 Net Income Attributable to Shareholders Up 11.3% to RMB29.2 Million Full Year of Fiscal 2012 Operating Cash Flow Increased to RMB353.9 Million Conference Call to be Held June 12, 2012 at 8:00 am ET HONG KONG, China,]

By | 2016-02-29T14:43:13+00:00 June 11th, 2012|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments

CO [China Cord Blood] 6-K: China Cord Blood Corporation Reports Financial Results for

[China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2012 4Q12 New Subscribers reached 14,336 4Q12 Net Income Attributable to Shareholders Up 11.3% to RMB29.2 Million Full Year of Fiscal 2012 Operating Cash Flow Increased to RMB353.9 Million Conference Call to be Held June 12, 2012 at 8:00 am ET HONG KONG, China,]

By | 2016-02-29T14:43:57+00:00 June 11th, 2012|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments

EGT [Entertainment Gaming Asia] DEF 14A: SCHEDULE 14A INFORMATION x o Check the appropriate

[SCHEDULE 14A INFORMATION x o Check the appropriate box: o Preliminary Proxy Statement o x Definitive Proxy Statement o Definitive Additional Materials o ENTERTAINMENT GAMING ASIA INC. Payment of Filing Fee (Check the appropriate box): x No fee required. o Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11. 1) Title of each class of securities to]

CO [Chinard Bloodrp] 6-K: (Original Filing)

[Chinard Bloodrporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2012 4Q12 New Subscribers reached 14,336 4Q12 Netome Attributable to Shareholders Up 11.3% to RMB29.2 Million Full Year of Fiscal 2012 Operatingsh Flowreased to RMB353.9 Millionnferencell to be Held June 12, 2012 at 8:00 am ET]

By | 2016-02-04T17:17:15+00:00 June 11th, 2012|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments
Skip to toolbar